The yield of early-pregnancy homeostasis of model assessment -insulin resistance (HOMA-IR) for predicting gestational diabetes mellitus in different body mass index and age groups
- PMID: 38017369
- PMCID: PMC10683100
- DOI: 10.1186/s12884-023-06113-3
The yield of early-pregnancy homeostasis of model assessment -insulin resistance (HOMA-IR) for predicting gestational diabetes mellitus in different body mass index and age groups
Abstract
Background: Early prediction of gestational diabetes mellitus(GDM) can be beneficial for lifestyle modifications to prevent GDM. The aim of this study was to investigate the predictive values of Homeostasis of Model Assessment -Insulin Resistance (HOMA-IR) in early pregnancy to predict GDM development in different body mass index (BMI) and age risk categories.
Materials and methods: This study is part of the Qazvin Maternal and Neonatal Metabolic Study (QMNMS) in Iran (2018-2021). In this prospective longitudinal study, pregnant women with a gestational age ≤ 14 weeks were enrolled in the study using convenience sampling method and were followed up until delivery to investigate risk factors for maternal and neonatal complications. Data collection was done using questionnaires. Serum sampling was done at a gestational age ≤ 14 weeks and sera were frozen until the end of study. GDM was diagnosed at 24-28 weeks of pregnancy using 75gr oral glucose tolerance test. Fasting blood glucose and insulin were measured in sera taken during early pregnancy in 583 participants. The Mann-Whitney U test, independent t-test, and Chi-square test were used for comparing variables between groups. The logistic regression analysis was used to examine the independent association of HOMA-IR with GDM development and receiver operating characteristic analysis was used for finding the best cut-off of HOMA-IR for predicting GDM.
Results: GDM was developed in 90 (15.4%) of the participants. The third HOMA-IR tertile was independently associated with 3.2 times higher GDM occurrence (95% CI:1.6-6.2, P = 0.001). Despite the high prevalence of GDM in advanced maternal age (GDM rate = 28.4%), HOMA-IR had no association with GDM occurrence in this high-risk group. In both normal BMI and overweight/obese groups, HOMA-IR was a moderate predictor of GDM development (AUC = 0.638, P = 0.005 and AUC = 0.622, P = 0.008, respectively). However, the best cut-off for predicting GDM was 2.06 (sensitivity 67.5%, specificity 61.1%) in normal BMI and 3.13 (sensitivity 64.6%, specificity61.8%) in overweight/obese BMI.
Conclusion: The present study revealed the necessity of considering the BMI and age risk groups when using the HOMA-IR index to predict GDM. Using lower cut-offs is more accurate for women with a normal BMI. In the advanced maternal age, there is no yield of HOMA-IR for predicting GDM.
Keywords: Advanced maternal age; Body mass index; Gestational Diabetes Mellitus; HOMA-IR.
© 2023. The Author(s).
Conflict of interest statement
The authors declare they have no competing interests.
Figures
Similar articles
-
The Quantose Insulin Resistance Test for Maternal Insulin Resistance: A Pilot Study.Am J Perinatol. 2022 Apr;39(5):513-518. doi: 10.1055/s-0040-1716730. Epub 2020 Sep 7. Am J Perinatol. 2022. PMID: 32894869
-
Predicting gestational diabetes mellitus during the first trimester using anthropometric measurements and HOMA-IR.J Endocrinol Invest. 2016 May;39(5):577-83. doi: 10.1007/s40618-015-0427-z. Epub 2016 Jan 12. J Endocrinol Invest. 2016. PMID: 26754418
-
Characteristics and pregnancy outcomes of subtypes of gestational diabetes mellitus based on HOMA-IR and BMI.Arch Gynecol Obstet. 2024 Nov;310(5):2355-2361. doi: 10.1007/s00404-024-07733-6. Epub 2024 Sep 17. Arch Gynecol Obstet. 2024. PMID: 39287682 Review.
-
Correlation Between Maternal and Fetal Insulin Resistance in Pregnant Women with Gestational Diabetes Mellitus.Clin Lab. 2018 Jun 1;64(6):945-953. doi: 10.7754/Clin.Lab.2018.171214. Clin Lab. 2018. PMID: 29945326
-
Effect of probiotics on pregnancy outcomes in gestational diabetes: systematic review and meta-analysis.Arch Gynecol Obstet. 2024 Aug;310(2):769-781. doi: 10.1007/s00404-023-07346-5. Epub 2024 Jan 18. Arch Gynecol Obstet. 2024. PMID: 38236281
Cited by
-
Predictive value of growth hormone and insulin-like growth factor-1 axis for gestational diabetes mellitus: a prospective cohort study.BMC Endocr Disord. 2025 May 19;25(1):132. doi: 10.1186/s12902-025-01953-w. BMC Endocr Disord. 2025. PMID: 40389967 Free PMC article.
-
Evaluating the Predictive Value of HOMA-IR in Gestational Diabetes: A Case-Control Study from Romania.Diagnostics (Basel). 2025 Jul 3;15(13):1704. doi: 10.3390/diagnostics15131704. Diagnostics (Basel). 2025. PMID: 40647703 Free PMC article.
-
Prediction Models for Gestational Diabetes Mellitus: Diagnostic Utility of Clinical and Biochemical Markers.Indian J Endocrinol Metab. 2025 May-Jun;29(3):295-302. doi: 10.4103/ijem.ijem_497_24. Epub 2025 Jun 28. Indian J Endocrinol Metab. 2025. PMID: 40688618 Free PMC article.
-
Impact of Sucrose Consumption on the Metabolic, Immune, and Redox Profile of Mice with Gestational Diabetes Mellitus.Life (Basel). 2025 Jun 20;15(7):989. doi: 10.3390/life15070989. Life (Basel). 2025. PMID: 40724491 Free PMC article.
-
Association of CDKAL1 gene polymorphisms variations with gestational diabetes mellitus risk in women: A case-control study and meta-analysis.BMC Endocr Disord. 2025 May 8;25(1):125. doi: 10.1186/s12902-025-01874-8. BMC Endocr Disord. 2025. PMID: 40340704 Free PMC article.
References
-
- - Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, Roura LC, McIntyre HD, Morris JL, Divakar H. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational Diabetes Mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015;131:173–211. doi: 10.1016/S0020-7292(15)30007-2. - DOI - PubMed
-
- - Saravanan P, Magee LA, Banerjee A, Coleman MA, Von Dadelszen P, Denison F, Farmer A, Finer S, Fox-Rushby J, Holt R, Lindsay RS. Gestational Diabetes: opportunities for improving maternal and child health. The Lancet Diabetes & Endocrinology. 2020;8(9):793–800. doi: 10.1016/S2213-8587(20)30161-3. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources